Ciprofloxacin is now a targeted option in surgery, not a default, because its adverse effects can seriously disrupt surgical recovery. This narrative review found the best use is in stable patients with culture-confirmed, susceptible gram-negative infection after source control, especially urinary infection needing oral step-down.
Most US surgical education fellowships require teaching and simulation work, but resources and leadership support differ a lot from program to program.